Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis

Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema

(2020) Siyao Liu et al.   World Journal of Surgical Oncology

RoB 2: a revised tool for assessing risk of bias in randomised trials

(2019) Jonathan A C Sterne et al.   BMJ-British Medical Journal

Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial

(2018) P. Roy et al.   BREAST CANCER RESEARCH AND TREATMENT

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

(2018) Viviana Galimberti et al.   LANCET ONCOLOGY

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2017) Armando E. Giuliano et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases

(2016) Armando E. Giuliano et al.   ANNALS OF SURGERY

Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial

(2016) Giuseppe Canavese et al.   ANNALS OF SURGICAL ONCOLOGY

Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? Five-Year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial: Assessment and Incidence of True Lymphedema

(2016) Neil Wetzig et al.   ANNALS OF SURGICAL ONCOLOGY

SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes

(2016) Corrado Tinterri et al.   BREAST

Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound

(2016) Amy E. Cyr et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Radioactive 125I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathway

(2015) Yunhong Tian et al.   BMC CANCER

Sentinel Lymph Node Based Management or Routine Axillary Clearance? Three-year Outcomes of the RACS Sentinel Node Biopsy Versus Axillary Clearance (SNAC) 1 Trial

(2014) Neil Wetzig et al.   ANNALS OF SURGICAL ONCOLOGY

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

(2013) Viviana Galimberti et al.   LANCET ONCOLOGY

Axillary Dissection Versus No Axillary Dissection in Older Patients With T1N0 Breast Cancer

(2012) Gabriele Martelli et al.   ANNALS OF SURGERY

Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis

(2011) Armando E. Giuliano   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Sentinel Lymph Node Biopsy in Breast Cancer

(2010) Umberto Veronesi et al.   ANNALS OF SURGERY

Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up

(2010) Gabriele Martelli et al.   ANNALS OF SURGICAL ONCOLOGY

Patient-Reported Outcomes in Sentinel Node–Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32

(2010) Stephanie R. Land et al.   JOURNAL OF CLINICAL ONCOLOGY

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection

(2010) Takamaru Ashikaga et al.   JOURNAL OF SURGICAL ONCOLOGY

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

(2010) David N Krag et al.   LANCET ONCOLOGY

A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer

(2009) Giorgio Zavagno et al.   ANNALS OF SURGERY

Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? One-Year Outcomes of Sentinel Node Biopsy Versus Axillary Clearance (SNAC): A Randomized Controlled Surgical Trial

(2008) Grantley Gill et al.   ANNALS OF SURGICAL ONCOLOGY

Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection – data from a prospective randomised trial

(2008) G. Helms et al.   EJSO